BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Corona Remedies Ltd IPO Subscription Status


Source:
BSE Last Updated: As per exchange snapshot available at 6:09:49 PM on December 8, 2025

Corona Remedies IPO: Subscription Status & Key Highlights

The Corona Remedies Ltd IPO opened on December 8, 2025 and recorded participation across retail, NII, and employee categories on Day 1. The QIB (ex-anchor) segment showed early-phase activity, while the anchor allocation was completed prior to the issue opening.

Monitoring category-wise subscription updates helps understand how different investor groups participate over the subscription period. The figures below reflect the status as per the latest exchange snapshot available at the time of reporting.

Corona Remedies IPO – Day 1 Subscription Status

As of December 8, 2025 (6:09:49 PM)

Overall subscription: 0.67× (Actual figures may vary with live exchange updates; readers should refer to the BSE/NSE book for the latest numbers.)

Category-Wise Subscription Snapshot

Investor Category

Subscription (times)

Shares Offered*

Shares Bid For

Amount (₹ Cr.)*

Anchor Investors

1.00

18,34,804

18,34,804

194.856

QIB (Ex-Anchor)

0.00

12,21,729

2,716

0.288

Non-Institutional Buyers

0.84

9,16,960

7,68,250

81.588

— bNII (₹10L+)

0.53

6,11,307

3,24,646

34.477

— sNII (<₹10L)

1.45

3,05,653

4,43,604

47.111

Retail Investors

0.96

21,39,573

20,44,994

217.178

Employees

1.47

58,036

85,568

9.087

Total (ex-anchor)

0.67

43,36,298

29,01,528

308.142

Total Applications Received: 1,14,665
*Calculated at the upper end of the price band.
**Anchor portion excluded from the “Total” shares offered.

Corona Remedies IPO – Issue Details

  • Total Issue Size: 61,71,101 shares (₹655.37 crore)

  • Issue Type: Book-built, entirely Offer for Sale (OFS)

  • Price Band: ₹1008–₹1062 per share

  • Lot Size: 14 shares

  • Listing: BSE & NSE

  • Employee Discount: ₹54 per share

Breakup of Shares Offered

Category

Shares Offered

Amount (₹ Cr.)

Size (%)

Anchor Investors

18,34,804

194.86

29.73%

QIB (ex-anchor)

12,21,729

19.80%

Overall QIB Quota (incl. Anchor)*

30,56,533

49.53%

NII

9,16,960

14.86%

Retail

21,39,573

34.67%

Employees

58,036

0.94%

Total

61,71,101

100%

*Anchor forms part of the QIB quota under applicable SEBI regulations.

Utilisation of Offer Proceeds

Since the issue comprises an Offer for Sale, proceeds will go to the selling shareholders. The company will not receive funds from this IPO.

Anchor Investor Allocation

Corona Remedies Ltd raised ₹194.86 crore from anchor investors ahead of the IPO.

Particulars

Details

Anchor Bid Date

December 5, 2025

Shares Allotted

18,34,804

Anchor Portion Size

₹194.86 crore

Anchor Investor Price

₹1,062 per share

Lock-in (30 days)

As per SEBI ICDR norms

Lock-in (90 days)

As per SEBI ICDR norms

Note: Actual lock-in distribution follows SEBI’s 30/90-day framework for anchor investors.

Corona Remedies IPO Lot Size

Application Type

Lots

Shares

Amount (₹) at Upper Band

Retail (Min)

1

14

₹14,868

Retail (Max)

13

182

₹1,93,284

S-HNI (Min)

14

196

₹2,08,152

S-HNI (Max)

67

938

₹9,96,156

B-HNI (Min)

68

952

₹10,11,024

Corona Remedies IPO – Timeline (Tentative)

Event

Date

IPO Opens

Mon, Dec 8, 2025

IPO Closes

Wed, Dec 10, 2025

Allotment

Thu, Dec 11, 2025

Refund Initiation

Fri, Dec 12, 2025

Shares Credit to Demat

Fri, Dec 12, 2025

Listing

Mon, Dec 15, 2025

UPI Mandate Cut-off

5 PM on Wed, Dec 10, 2025

Corona Remedies Ltd – Financial Highlights

(Restated consolidated financials as disclosed in offer documents)

Metric (₹ crore)

30 Jun 2025

FY25

FY24

FY23

Assets

1,012.38

929.86

830.58

595.02

Total Income

348.56

1,202.35

1,020.93

891.10

PAT

46.20

149.43

90.50

84.93

EBITDA

71.80

245.91

161.19

135.03

Net Worth

607.02

606.34

480.41

408.52

Total Borrowing

106.65

62.70

134.14

2.33

Key Performance Indicators

KPI

Value

ROE

27.50%

ROCE

41.32%

Debt/Equity

0.10

RoNW

24.65%

PAT Margin

12.49%

EBITDA Margin

20.55%

P/BV

10.71

About the Company

Incorporated in 2004, Corona Remedies Ltd operates across therapeutic segments including women’s healthcare, cardio-diabeto, urology, and pain management.
As of June 30, 2025, the company had:

  • 71 brands,

  • 2,671 medical representatives,

  • Operations across 22 states, and

  • Two manufacturing facilities in Gujarat with an installed capacity of 1,285.44 million units annually.

Conclusion

The Corona Remedies IPO witnessed participation across retail, NII, and employee categories on Day 1, with anchor activity concluded ahead of the opening. Subscription levels may continue to evolve through the bidding period. Investors should track real-time updates directly from the exchanges for the latest book status.

Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Corona Remedies.

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,600+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|